Trials / Conditions / HGG
HGG
4 registered clinical trials studyying HGG — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) NCT07210632 | Eben Rosenthal | EARLY_Phase 1 |
| Recruiting | Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoin NCT07179328 | Sunnybrook Health Sciences Centre | Phase 1 |
| Recruiting | A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797 | Fore Biotherapeutics | Phase 2 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With A NCT05538130 | Pfizer | Phase 1 |